Information  X 
Enter a valid email address

Tissue Regenix Grp PLC Ord0.1P (TRX)

Related News

10-Oct-2011 07:51 AM

Tissue Regenix makes a loss but remains focussed on expansion

Tissue Regenix, the regenerative medical devices company has announced interim results for the six months ended 31 July 2011. The company increased investment in product programmes designed to expand its product offering which resulted in an increased lo
13-Jun-2011 08:42 AM

New CFO for Tissue Regenix

Tissue Regenix, the regenerative medical device company, has confirmed that Ian Jefferson has begun his appointment as Chief Financial Officer (CFO) and been appointed to the Board of Directors with immediate effect. Jefferson appointment as CFO means
03-Jun-2011 10:36 AM

Tissue Regenix aims for global leadership

Tissue Regenix Group told shareholders at its AGM that impressive progress has been made in making the company a global leader in regenerative medicine. John Samuel, Executive Chairman, said: "Although it will take time to exploit the potential of
11-May-2011 11:16 AM

Tissue Regenix receives promising results for vascular patch

Regenerative medical device company Tissue Regenix Group plc reported positive results from clinical evaluation of its dCELL Vascular Patch in the repair of peripheral arteries. Significantly improved blood flow was reported in all but one case with no
04-May-2011 12:19 PM

Tissue Regenix posts £5.67m loss

Regenerative medical devices company Tissue Regenix Group plc posted a pre-tax loss of £5.67m for the year to end-January, against the previous loss of £0.74m. The result included a £3.7m non-cash loss arising from the company's reverse acquisition
21-Apr-2011 11:56 AM

Tissue Regenix in $1bn global heart valve market deal

Medical device company Tissue Regenix Group plc has entered a commercialisation and IP agreement with clinical collaborators the Pontifical Catholic University of Parana (PUCPR) and Cardioprotese Ltda, based in Brazil. It says the deal represents a major
29-Mar-2011 10:52 AM

Tissue Regenix names Ian Jefferson as CFO

Regenerative medical device company Tissue Regenix Group plc has appointed Ian Jefferson as chief financial officer, to start by June 13. He replaces the current CFO, Mike Bretherton, who will become a non-executive director. Until last year Jefferson
16-Dec-2010 11:14 AM

Tissue Regenix in pilot study with NHS

Implants developer Tissue Regenix Group plc said its partner NHS Blood and Transplant has initiated a pilot study to evaluate the use of decellularised human donor skin grafts in the treatment of chronic non-healing wounds, using the company's propri
20-Oct-2010 09:25 AM

Tissue Regenix ready to start marketing

Regenerative medical devices company Tissue Regenix reported a pre-tax loss of £0.7m for the six months to July 31, down from £0.9m. The result, its first since listing on AIM and raising £4.5m, was before deemed reverse acquisition and listing costs of
20-Oct-2010 07:22 AM

Tissue Regenix narrows H1 loss to £0.7m

Story provided by StockMarketWire.com...
10-Aug-2010 11:40 AM

Tissue Regenix gets European stamp of approval

Medical technology company Tissue Regenix has received European CE Marking for its dCELL vascular patch. It will now work towards receiving FDA approval for the US. Tissue Regenix, which joined AIM in June via a reverse takeover of Oxeco, will manufact
05-Aug-2010 03:51 PM

Tissue Regenix granted two patents

Tissue Regenix has been granted two new patents in the US and Australia. Tissue Regenix - a medical technology company focused on the development and commercialisation of acellular tissue replacement products to address the chronic global shortfalls in d
29-Jun-2010 04:25 PM

IP Group portfolio firm Tissue Regenix dealing on AIM

IP Group portfolio company Tissue Regenix Group started trading on AIM today (29 June) following the reverse takeover of Oxeco plc. Tissue Regenix is a medical technology company focused on the development and commercialisation of acellular tissue replac

a d v e r t i s e m e n t